XML 25 R4.htm IDEA: XBRL DOCUMENT v3.23.2Close
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 2,617.8 $ 3,419.3
Marketable securities 3,460.5 1,473.5
Inventory 1,333.5 1,344.4
Other current assets 895.9 1,417.6
Total current assets 10,431.7 9,791.2
Marketable securities 1,208.0 705.7
Property, plant and equipment, net 3,307.2 3,298.6
Operating lease assets 366.5 403.9
Intangible assets, net 1,776.4 1,850.1
Goodwill 5,753.7 5,749.0
Deferred tax asset 1,208.4 1,226.4
Investments and other assets 1,104.9 1,529.2
Total assets 25,156.8 24,554.1 Close
Current liabilities:    
Taxes payable 260.0 259.9
Accounts payable 445.4 491.5
Accrued expense and other 2,481.1 2,521.4
Total current liabilities 3,186.5 3,272.8
Notes payable 6,284.6 6,281.0
Deferred tax liability 143.9 334.7
Long-term operating lease liabilities 304.4 333.0
Other long-term liabilities 776.9 944.2
Total liabilities 10,696.3 11,165.7 Close
Commitments, contingencies and guarantees
Biogen Idec Inc. shareholders' equity    
Preferred stock, par value $0.001 per share 0.0 0.0
Common stock, par value $0.0005 per share 0.1 0.1
Additional paid-in capital 170.7 73.3
Accumulated other comprehensive income (loss) (172.8) (164.9)
Retained earnings 17,446.0 16,466.5
Treasury stock, at cost (2,977.1) (2,977.1)
Total Biogen Inc. shareholders’ equity 14,466.9 13,397.9
Noncontrolling interests (6.4) (9.5)
Total equity 14,460.5 13,388.4 Close
Total liabilities and equity 25,156.8 24,554.1
Nonrelated Party    
Current assets:    
Accounts receivable, net 1,685.9 1,705.0
Related Party    
Current assets:    
Accounts receivable, net $ 438.1 $ 431.4